Is ARTLW or XYLD a better dividend investment in 2026?

ARTLW currently yields 35714.29% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: ARTLW offers higher current income.

What is the dividend yield difference between ARTLW and XYLD?

ARTLW has a forward dividend yield of 35714.29% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 35703.31 percentage points.

Home › Compare › ARTLW vs XYLD

ARTLW vs XYLD: Dividend Comparison 2026

ARTLW yields 35714.29% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARTLW wins by $1.6752839315172392e+22M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARTLW

● Live price

35714.29%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.6752839315172392e+22M

Annual income

$16,661,069,746,468,538,000,000,000,000.00

Full ARTLW calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — ARTLW vs XYLD

📍 ARTLW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARTLW	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARTLW + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARTLW pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARTLW

Annual income on $10K today (after 15% tax)

$3,035,714.29/yr

After 10yr DRIP, annual income (after tax)

$14,161,909,284,498,257,000,000,000,000.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, ARTLW beats the other by $14,161,909,284,498,257,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARTLW + XYLD for your $10,000?

ARTLW: 50%XYLD: 50%

100% XYLD50/50100% ARTLW

Portfolio after 10yr

$8.376419657586196e+21M

Annual income

$8,330,534,873,234,269,000,000,000,000.00/yr

Blended yield

99.45%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARTLW buys

XYLD buys

No recent congressional trades found for ARTLW or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARTLWXYLD

Forward yield	35714.29% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.6752839315172392e+22M	$25.3K ✓
Annual income after 10y	$16,661,069,746,468,538,000,000,000,000.00 ✓	$3,219.02
Total dividends collected	$1.6746806834400388e+22M	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ARTLW vs XYLD ($10,000, DRIP)

Year	ARTLW Portfolio	ARTLW Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$3,582,129	$3,571,428.57	$10,818	$1,098.39	+$3.57M → ARTLW
2	$1,199,469,917	$1,195,637,039.86	$11,738	$1,222.51	+$1199.46M → ARTLW
3	$375,448,961,128	$374,165,528,316.29	$12,774	$1,364.64	+$375448.95M → ARTLW
4	$109,858,226,763,271	$109,456,496,374,863.77	$13,944	$1,527.86	+$109858226.75M → ARTLW
5	$30,049,803,731,826,150	$29,932,255,429,189,452.00	$15,270	$1,715.87	+$30049803731.81M → ARTLW
6	$7,683,972,846,060,485,000	$7,651,819,556,067,430,000.00	$16,775	$1,933.09	+$7683972846060.47M → ARTLW
7	$1,836,848,834,513,013,000,000	$1,828,626,983,567,728,800,000.00	$18,490	$2,184.87	+$1836848834513013.00M → ARTLW
8	$410,500,120,243,639,900,000,000	$408,534,691,990,711,000,000,000.00	$20,450	$2,477.63	+$410500120243639936.00M → ARTLW
9	$85,765,952,059,675,500,000,000,000	$85,326,716,931,014,800,000,000,000.00	$22,697	$2,819.19	+$85765952059675492352.00M → ARTLW
10	$16,752,839,315,172,392,000,000,000,000	$16,661,069,746,468,538,000,000,000,000.00	$25,280	$3,219.02	+$1.6752839315172392e+22M → ARTLW

ARTLW vs XYLD: Complete Analysis 2026

ARTLW — Stock

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Full ARTLW Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this ARTLW vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARTLW vs SCHD ARTLW vs JEPI ARTLW vs O ARTLW vs KO ARTLW vs MAIN ARTLW vs QYLD ARTLW vs JEPQ ARTLW vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.